Stay updated on Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial

Sign up to get notified when there's something new on the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T03:53:08.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The Record History now includes a new version entry (v3.5.0) and removes the earlier version (v3.4.3).
    Difference
    0.1%
    Check dated 2026-03-20T04:00:00.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added to the history and revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-12T21:33:04.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the history, and the funding notice banner and the previous revision (v3.4.1) were removed.
    Difference
    0.7%
    Check dated 2026-02-12T02:06:16.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Additions include a general site status notice about government funding and the current revision tag (v3.4.1). Deletion removes the previous revision tag (v3.4.0).
    Difference
    0.7%
    Check dated 2026-02-04T12:34:41.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    UI-related updates include showing the glossary, color-coded highlights for changes, and revision labels (v3.4.0) while the changes modify 'No FEAR Act' data text and versioning notes, affecting display rather than core study content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-01-28T11:09:46.000Z thumbnail image

Stay in the know with updates to Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page.